Eli Lilly (LLY) Equity Ratio (2009 - 2026)

Eli Lilly (LLY) has reported Equity Ratio for 18 consecutive years, with 0.27 the latest figure, recorded in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.27, up 1196.34% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.27 (up 1196.34% YoY), and the FY2025 annual result was 0.24, up 7448.86% from the prior year.
• Equity Ratio was 0.27 for Q1 2026 at Eli Lilly, up from 0.24 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.27 in Q1 2026 and troughed at 0.09 in Q2 2022.
• Average Equity Ratio over 5 years is 0.01, with a median of 0.02 recorded in 2025.
• Year-over-year, Equity Ratio sank 3106.51% in 2024 and soared 7448.86% in 2025.
• Over 5 years, Equity Ratio stood at 0.0 in 2022, then sank by 2660.06% to 0.05 in 2023, then soared by 106.64% to 0.0 in 2024, then surged by 7448.86% to 0.24 in 2025, then climbed by 13.44% to 0.27 in 2026.
• Per Business Quant data, the three most recent Equity Ratio figures were 0.27 in Q1 2026, 0.24 in Q4 2025, and 0.21 in Q3 2025.